Noninvasive measurements for studying the tumoral pharmacokinetics of platinum anticancer drugs in solid tumors

Advanced Drug Delivery Reviews

Volumn 41, Issue 1, 2000, Pages 111-126

  Dowell, James A ^a   Sancho, Alfredo R ^b   Anand, Deepak ^c   Wolf, Walter ^d  

^a WYETH AYERST RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Skilled Care Pharmacy   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anticancer drugs; Carboplatin; Cisplatin; Imaging; Noninvasive measurements; Pharmacokinetics

Indexed keywords

MEDICAL IMAGING; METABOLITES; ONCOLOGY; PLATINUM; RADIOISOTOPES;

ANTICANCER DRUGS;

PHARMACOKINETICS;

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PLATINUM COMPLEX; RADIOISOTOPE;

DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXPOSURE; DRUG LABELING; DRUG RESEARCH; DRUG SCREENING; DRUG TUMOR LEVEL; HUMAN; INFORMATION PROCESSING; ISOTOPE LABELING; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; TUMOR; VALIDATION PROCESS;

EID: 0034000245     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00059-9     Document Type: Article

References (38)

1. Wolf W. Imaging can be much more than pretty pictures. Pharm. Res. 12:1995;1821-1822.
2. Jain R.K., Weissbrod J., Wei J. Mass transfer in tumors: characterization and applications in chemotherapy. Adv. Cancer Res. 33:1980;251-311.
3. Sung C., Youle R.J., Dedrick R.L. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding. Cancer Res. 50:1990;7382-7392.
4. Curti B.D., Urba W.J., Alvord W.G., Janik J.E., Smith J.W., Madara K., Longo D.L. Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res. 53:1993;2204-2207.
5. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am. J. Physiol. 267:1994;C195-C203.
6. Spiller M., Merker P.C., Iatropoulos M.J., Childress S.M., Williams G.M., Kasoff S.S. Correlation of relaxometry and histopathology: the transplantable human glioblastoma SF295 grown in athmic nude mice. J. Neuro-Oncol. 25:1995;113-126.
7. Hanigan M.H., Frierson H.F., Brown J.E., Lovell M.A., Taylor P.T. Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res. 54:1994;286-290.
8. Wolf W., Manaka R.C., Leh F.K.V. The use of radionuclides of platinum. J. Clin. Hematol. Oncol. 7:1977;741-749.
9. 195mPt-cis-dichlorodiammine platinum (II) and platinum compounds. Radiopharmaceutical Dosimetry, (FDA). 76-8044:1976;452-459.
10. 191Pt. Int. J. Appl. Radiat. Isotop. 36:1985;181-184.
11. Lange R.C., Spencer R.P., Harder H.C. Synthesis and biodistribution of a radiolalebed antitumor agent, cis-dichloro-diammine-platinum(II). J. Nucl. Med. 14:1973;191-195.
12. Willins J.D., Sgouros G. Modeling analysis of platinum-195m for targeting individual blood-borne cells in adjuvant radioimmunotherapy. J. Nucl. Med. 36:1995;135-319.
13. Dhara S.C. A rapid method for the synthesis of cisplatin. Indian J. Chem. 8:1970;193-197.
14. 195mPt-cis-diammine-dichloro-platinum. New developments in Radiopharmaceuticals and Labelled Compounds. Vol. II:1973;205-221 IAEA, Vienna.
15. 195mPt-cis-dichlorodiammine platinum (II). J. Clin. Hematol. Oncol. 7:1977;79-85.
16. 195mPt labeled antitumor drug, cis-dichlorodiammine platinum II, Cis-DDP. Radiochim. Acta. 31:1982;27-33.
17. 195mPt labelled anti-tumour complexes. J. Lab. Comp. Radiopharm. 29:1991;1121-1130.
18. 195mPt]-cisplatin suitable for clinical studies. Appl. Radiat. Isotop. 43:1992;809-814.
19. 195mPt-carboplatin. Pharm. Res. 11:1994;S34.
20. Rosenberg B., Van Camp L., Trosko J.E., Mansour V.H. Platinum compounds: A new class of potent antitumor agents. Nature. 222:1969;385-386.
21. Manaka R.C., Schumitzky A., Wolf W. Symbolic programs for structural identification in linear pharmacokinetic systems. Comp. Prog. Biomed. 13:1981;203-216.
22. D.Z. D'Argenio, A. Schumitzky, ADAPT-II. Pharmacokinetic/Pharmacodynamic Systems Analysis Software, User's Guide to Release 4, March 1997, University of Southern California, CA.
23. Manaka R.C., Wolf W. Radiopharmacokinetics of cisplatin. Crooke S., Carter S., Prestayko A. Cisplatin - Current Status and New Developments. 1980;271-283 Academic Press, NewYork.
24. Brechner R.R., D'Argenio D.Z., Dahalan R., Wolf W. Noninvasive estimation of bound platinum compounds in the kidney using a radiopharmacokinetic model. J. Pharm Sci. 75:1986;873-877.
25. Shani J., Bertram J., Russell C., Dahalan R., Chen D.C.P., Parti R., Ahmadi J., Kempf R.A., Kawada T.K., Muggia F.M., Wolf W. Noninvasive monitoring of drug biodistribution and metabolism: Studies with intraarterial Pt-195m-cisplatin. Cancer Res. 49:1989;1877-1881.
26. NIH Image, IMAGE v.1.52, US National Institutes of Health, Public Domain, 1994, The website for this program is http://rsb.info.nih.gov/nih-image/, The current (1999) version of this image analysis program is 1.62.
27. Parti R., Wolf W. Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin. Cancer Chemother. Pharmacol. 26:1990;188-192.
28. D'Argenio D.Z., Schumitsky A. A program package for simulation and and parameter estimation in pharmacokinetic models. Comp. Prog. Biomed. 9:1979;115-134.
29. Manaka R.C., Wolf W. Distribution of cisplatin in blood. Chem.-Biol. Interact. 22:1978;353-358.
30. 195mPt-cisplatin, validation of model estimates based on subcellular distribution studies, #AAG0574300, Diss. Abst. Int. 54-11B (1993) 5614.
31. 195mPt cisplatin. Proc. Am. Assoc. Cancer Res. 36:(2142):1995;360.
32. S. Madajewicz, N. Chowhan, A. Tfayli, C. Roque, A. Meek, R. Davis, W. Wolf, C. Cabahug, L. Russo, P. Roche, J. Manzione, I. Affif, M. Shady, P. Hentschel, H. Atkins, A. Braun, Therapy of high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer (1999), in press.
33. Jonson R., Mattsson S., Unsgaard B. A method for in vivo analysis of platinum after chemotherapy with cisplatin. Phys. Med. Biol. 33:1988;847-857.
34. Jonson R., Borjesson J., Mattsson S., Unsgaard B., Wallgren A. Uptake and retention of platinum in patients undergoing cisplatin therapy. Acta Oncol. 30:1991;315-319.
35. Gorodetsky R., Vexler A., Mou X., Kaufman B., Loewenthal E. A sensitive noninvasive analysis of Pt in external tissues: Followup of Pt deposition following cisplatin treatment. Med. Phys. 20:1993;1007-1012.
36. Ali P.A., Lewis D.G., el-Sharkawi A.M., al-Sadhan F.A., Evans C.J., Hancock D.A., Dutton J. Initial measurements of platinum concentration in head and neck tumors using X-ray fluorescence. Basic Life Sci. 60:1993;281-284.
37. Ali P.A., Bennet C., el-Sharkawi A.M., Hancock D.A. Optimisation of a polarised X-ray source for the in vivo measurement of platinum in head and neck tumours. Appl. Radiat. Isotop. 49:1998;647-650.
38. 195Pt NMR. J. Mag. Reson. 133:1998;115-122.